CNTA
Centessa Pharmaceuticals
CNTA • NASDAQ
Centessa Pharmaceuticals is a pharmaceutical preparations company trading on NASDAQ, led by CEO Mario Alberto Accardi.
CEOMario Alberto Accardi
Next Earnings
Upcoming earnings announcement for Centessa Pharmaceuticals
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.39
Revenue Estimate
$382.2K
Earnings History
Past 11 earnings reports for Centessa Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.41Est: -$0.39 | -5.1% | -Est: $2.8M | -100.0% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.38Est: -$0.35 | -8.6% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.20Est: -$0.28 | +28.6% | $15.0M | — | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.58Est: -$0.35 | -65.7% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.37Est: -$0.42 | +11.9% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.40Est: -$0.39 | -2.6% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.38Est: -$0.43 | +11.6% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.38Est: -$0.48 | +20.8% | $6.9M | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.40Est: -$0.52 | +23.1% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.26Est: -$0.49 | +46.9% | - | — | — |
| May 12, 2023 | Q1 2023 | -$0.53Est: -$0.33 | -60.6% | - | — | — |